Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16781368 | 0.76 | KMT2A (0.44) | MEN1KMT2ASMN1; SMN2L3MBTL1 | |
| SCHEMBL16804113 | 0.76 | KMT2A (0.44) | MEN1KMT2ASMN1; SMN2L3MBTL1 | |
| SCHEMBL18673134 | 0.73 | — | — | |
| SCHEMBL16804114 | 0.72 | MEN1 (0.35) | MEN1NPBWR1KMT2AL3MBTL1 | |
| SCHEMBL19576642 | 0.68 | CA1 (0.33) | CA1CA2CA4 | |
| SCHEMBL6033629 | 0.67 | KEAP1 (0.36) | L3MBTL1 | |
| SCHEMBL19346761 | 0.65 | DRD2 (0.46) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL28028180 | 0.64 | CYP1A2 (0.42) | CA1CA2CA4 | |
| SCHEMBL6253050 | 0.64 | CYP1A2 (0.42) | CA1CA2CA4 | |
| SCHEMBL12942860 | 0.63 | PEPD (0.41) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170192025-A1 | METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY | AMERITOX LLC (US) | 2017-07-06 | — | — | US | disclosed |